147 related articles for article (PubMed ID: 29610157)
1. Clinical Benefit of NMDA Receptor Antagonists in a Patient With
Ueda K; Serajee F; Huq AM
Pediatrics; 2018 Apr; 141(Suppl 5):S390-S394. PubMed ID: 29610157
[TBL] [Abstract][Full Text] [Related]
2. An Infant With Epilepsy and Recurrent Hemiplegia due to Compound Heterozygous Variants in ATP1A2.
Wilbur C; Buerki SE; Guella I; Toyota EB; Evans DM; McKenzie MB; Datta A; Michoulas A; Adam S; Van Allen MI; Nelson TN; Farrer MJ; Connolly MB; Demos M
Pediatr Neurol; 2017 Oct; 75():87-90. PubMed ID: 28811059
[TBL] [Abstract][Full Text] [Related]
3. A novel heterozygous ATP1A2 pathogenic variant in a Chinese child with MELAS-like alternating hemiplegia.
Zhang X; Qiu S; Yang L; Li Y; Xu L; Xu N; Mi C; Li M
Mol Genet Genomic Med; 2023 May; 11(5):e2146. PubMed ID: 36749827
[TBL] [Abstract][Full Text] [Related]
4. ATP1A2-related epileptic encephalopathy and movement disorder: Clinical features of three novel patients.
Córdoba NM; Lince-Rivera I; Gómez JLR; Rubboli G; De la Rosa SO
Epileptic Disord; 2024 Jun; 26(3):332-340. PubMed ID: 38512072
[TBL] [Abstract][Full Text] [Related]
5. Alternating hemiplegia of childhood: no mutations in the second familial hemiplegic migraine gene ATP1A2.
Kors EE; Vanmolkot KR; Haan J; Kheradmand Kia S; Stroink H; Laan LA; Gill DS; Pascual J; van den Maagdenberg AM; Frants RR; Ferrari MD
Neuropediatrics; 2004 Oct; 35(5):293-6. PubMed ID: 15534763
[TBL] [Abstract][Full Text] [Related]
6. Prolonged sporadic hemiplegic migraine associated with a novel de novo missense ATP1A2 gene mutation.
De Sanctis S; Grieco GS; Breda L; Casali C; Nozzi M; Del Torto M; Chiarelli F; Verrotti A
Headache; 2011 Mar; 51(3):447-450. PubMed ID: 21352219
[TBL] [Abstract][Full Text] [Related]
7. Does memantine improve memory in subjects with focal-onset epilepsy and memory dysfunction? A randomized, double-blind, placebo-controlled trial.
Leeman-Markowski BA; Meador KJ; Moo LR; Cole AJ; Hoch DB; Garcia E; Schachter SC
Epilepsy Behav; 2018 Nov; 88():315-324. PubMed ID: 30449328
[TBL] [Abstract][Full Text] [Related]
8. A wide clinical phenotype spectrum in patients with ATP1A2 mutations.
Al-Bulushi B; Al-Hashem A; Tabarki B
J Child Neurol; 2014 Feb; 29(2):265-8. PubMed ID: 24097848
[TBL] [Abstract][Full Text] [Related]
9. Early onset severe ATP1A2 epileptic encephalopathy: Clinical characteristics and underlying mutations.
Moya-Mendez ME; Mueller DM; Pratt M; Bonner M; Elliott C; Hunanyan A; Kucera G; Bock C; Prange L; Jasien J; Keough K; Shashi V; McDonald M; Mikati MA
Epilepsy Behav; 2021 Mar; 116():107732. PubMed ID: 33493807
[TBL] [Abstract][Full Text] [Related]
10. Prolonged hemiplegic episodes in children due to mutations in ATP1A2.
Jen JC; Klein A; Boltshauser E; Cartwright MS; Roach ES; Mamsa H; Baloh RW
J Neurol Neurosurg Psychiatry; 2007 May; 78(5):523-6. PubMed ID: 17435187
[TBL] [Abstract][Full Text] [Related]
11. The clinical spectrum associated with ATP1A2 variants in Chinese pediatric patients.
Dai L; Ding C; Tian X; Liu M; Ma Y; Chen C; Ren X; Li H
Brain Dev; 2023 Sep; 45(8):422-431. PubMed ID: 37142513
[TBL] [Abstract][Full Text] [Related]
12. Two de novo mutations in the Na,K-ATPase gene ATP1A2 associated with pure familial hemiplegic migraine.
Vanmolkot KR; Kors EE; Turk U; Turkdogan D; Keyser A; Broos LA; Kia SK; van den Heuvel JJ; Black DF; Haan J; Frants RR; Barone V; Ferrari MD; Casari G; Koenderink JB; van den Maagdenberg AM
Eur J Hum Genet; 2006 May; 14(5):555-60. PubMed ID: 16538223
[TBL] [Abstract][Full Text] [Related]
13. Treatment with Oral ATP decreases alternating hemiplegia of childhood with de novo ATP1A3 Mutation.
Ju J; Hirose S; Shi XY; Ishii A; Hu LY; Zou LP
Orphanet J Rare Dis; 2016 May; 11(1):55. PubMed ID: 27146299
[TBL] [Abstract][Full Text] [Related]
14. A novel ATP1A2 gene mutation in familial hemiplegic migraine and epilepsy.
Costa C; Prontera P; Sarchielli P; Tonelli A; Bassi MT; Cupini LM; Caproni S; Siliquini S; Donti E; Calabresi P
Cephalalgia; 2014 Jan; 34(1):68-72. PubMed ID: 23918834
[TBL] [Abstract][Full Text] [Related]
15. A novel de novo nonsense mutation in ATP1A2 associated with sporadic hemiplegic migraine and epileptic seizures.
Gallanti A; Tonelli A; Cardin V; Bussone G; Bresolin N; Bassi MT
J Neurol Sci; 2008 Oct; 273(1-2):123-6. PubMed ID: 18644608
[TBL] [Abstract][Full Text] [Related]
16. Hemiplegic migraine type 2 with new mutation of the ATP1A2 gene in Japanese cases.
Oda I; Danno D; Saigoh K; Wolf J; Kawashita N; Hirano M; Samukawa M; Kitamura S; Kikui S; Takeshima T; Mitsui Y; Kusunoki S; Nagai Y
Neurosci Res; 2022 Jul; 180():83-89. PubMed ID: 35257835
[TBL] [Abstract][Full Text] [Related]
17. Alternating hemiplegia of childhood or familial hemiplegic migraine? A novel ATP1A2 mutation.
Swoboda KJ; Kanavakis E; Xaidara A; Johnson JE; Leppert MF; Schlesinger-Massart MB; Ptacek LJ; Silver K; Youroukos S
Ann Neurol; 2004 Jun; 55(6):884-7. PubMed ID: 15174025
[TBL] [Abstract][Full Text] [Related]
18. A case of familial hemiplegic migraine associated with a novel ATP1A2 gene mutation.
De Cunto A; Bensa M; Tonelli A
Pediatr Neurol; 2012 Aug; 47(2):133-6. PubMed ID: 22759692
[TBL] [Abstract][Full Text] [Related]
19. Two novel functional mutations in the Na+,K+-ATPase alpha2-subunit ATP1A2 gene in patients with familial hemiplegic migraine and associated neurological phenotypes.
Castro MJ; Nunes B; de Vries B; Lemos C; Vanmolkot KR; van den Heuvel JJ; Temudo T; Barros J; Sequeiros J; Frants RR; Koenderink JB; Pereira-Monteiro JM; van den Maagdenberg AM
Clin Genet; 2008 Jan; 73(1):37-43. PubMed ID: 18028456
[TBL] [Abstract][Full Text] [Related]
20. Novel missense mutation in the ATP1A2 gene associated with atypical sporapedic hemiplegic migraine.
Rispoli MG; Di Stefano V; Mantuano E; De Angelis MV
BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31586957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
